540 related articles for article (PubMed ID: 16650951)
81. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999.
Turnidge J; Bell J; Biedenbach DJ; Jones RN
Int J Antimicrob Agents; 2002 Jul; 20(1):10-7. PubMed ID: 12127706
[TBL] [Abstract][Full Text] [Related]
82. Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance.
Crandon JL; Kuti JL; Jones RN; Nicolau DP
Ann Pharmacother; 2009 Feb; 43(2):220-7. PubMed ID: 19193582
[TBL] [Abstract][Full Text] [Related]
83. In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group.
Biedenbach DJ; Johnson DM; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):325-31. PubMed ID: 10668592
[TBL] [Abstract][Full Text] [Related]
84. Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004).
Rhomberg PR; Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):249-57. PubMed ID: 16466890
[TBL] [Abstract][Full Text] [Related]
85. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Spencer RC
Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
[TBL] [Abstract][Full Text] [Related]
86. [Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)].
Rodríguez CH; Juárez J; de Mier C; Pugliese L; Blanco G; Vay C; Famiglietti A
Medicina (B Aires); 2003; 63(1):21-7. PubMed ID: 12673956
[TBL] [Abstract][Full Text] [Related]
87. Bacterial Pathogens Isolated from Patients with Bloodstream Infections in Latin America, 1997: Frequency of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program.
Sader HS; Pfaller MA; Jones RN; Doern GV; Gales AC; Winokur PL; Kugler KC
Braz J Infect Dis; 1999 Jun; 3(3):97-110. PubMed ID: 11097713
[TBL] [Abstract][Full Text] [Related]
88. Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014).
Sader HS; Castanheira M; Farrell DJ; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2015 Dec; 83(4):389-94. PubMed ID: 26162518
[TBL] [Abstract][Full Text] [Related]
89. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
90. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
91. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
Ko WC; Hsueh PR
J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
[TBL] [Abstract][Full Text] [Related]
92. Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program.
Deshpande LM; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2004 Aug; 49(4):231-6. PubMed ID: 15313526
[TBL] [Abstract][Full Text] [Related]
93. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].
López-Yeste M; Xercavins M; Lite J; Cuchí E; Garau J
Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):211-4. PubMed ID: 9044634
[TBL] [Abstract][Full Text] [Related]
94. Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
Tumah H
Chemotherapy; 2005 May; 51(2-3):80-5. PubMed ID: 15870501
[TBL] [Abstract][Full Text] [Related]
95. [Surveillance of bacterial resistance in Shanghai].
Wang F; Zhu D; Hu F
Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):17-9. PubMed ID: 11798844
[TBL] [Abstract][Full Text] [Related]
96. A comparison of the antimicrobial resistance patterns of gram-negative bacilli isolated from community-private and university-affiliated hospitals from Puerto Rico.
Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermúdez M; Colón M
P R Health Sci J; 2003 Sep; 22(3):265-71. PubMed ID: 14619453
[TBL] [Abstract][Full Text] [Related]
97. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
98. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates.
Giamarellou H; Sahin A; Chryssouli Z
Drugs Exp Clin Res; 1987; 13(3):149-53. PubMed ID: 3622243
[TBL] [Abstract][Full Text] [Related]
99. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
Sader HS; Jones RN
Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291
[TBL] [Abstract][Full Text] [Related]
100. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
Jones RN; Li Q; Kohut B; Biedenbach DJ; Bell J; Turnidge JD
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):63-71. PubMed ID: 16368476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
